Farmacosmo Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	16	18	36	27	73	-
Market Cap Growth	-32.00%	-51.70%	36.86%	-63.49%	-	-
Enterprise Value	22	24	39	31	66	-
Last Close Price	0.41	0.45	0.94	0.69	1.95	-
Forward PE	-	-	-	-	65.00	-
PS Ratio	0.28	0.31	0.57	0.37	1.10	-
PB Ratio	2.99	3.33	3.37	1.73	3.84	-
P/TBV Ratio	-	-	-	-	18.75	-
P/FCF Ratio	29.84	33.20	-	-	-	-
P/OCF Ratio	28.58	31.80	-	-	-	-
PEG Ratio	-	0.59	0.59	0.59	0.59	-
EV/Sales Ratio	0.40	0.43	0.60	0.43	1.00	-
EV/EBITDA Ratio	-	-	110.00	-	-	-
EV/FCF Ratio	41.99	44.99	-	-	-	-
Debt / Equity Ratio	1.43	1.43	0.68	0.44	0.10	0.64
Debt / EBITDA Ratio	-	-	20.88	-	-	0.46
Debt / FCF Ratio	14.24	14.24	-	-	-	-
Net Debt / Equity Ratio	1.25	1.25	0.39	0.11	-0.26	-0.82
Net Debt / EBITDA Ratio	-1.57	-1.57	11.99	-3.89	3.64	-0.59
Net Debt / FCF Ratio	12.45	12.45	-1.93	-0.31	-	1.85
Asset Turnover	1.90	1.90	1.91	1.92	2.66	6.01
Inventory Turnover	8.29	8.29	7.60	11.94	19.50	37.06
Quick Ratio	0.50	0.50	0.43	0.65	0.95	0.80
Current Ratio	0.78	0.78	0.98	1.08	1.22	1.04
Return on Equity (ROE)	-57.08%	-57.08%	-23.43%	-22.88%	-20.06%	54.37%
Return on Assets (ROA)	-12.04%	-12.04%	-4.24%	-5.36%	-4.12%	6.84%
Return on Invested Capital (ROIC)	-47.72%	-42.15%	-14.23%	-20.90%	-23.17%	-
Return on Capital Employed (ROCE)	-70.80%	-70.80%	-18.20%	-18.00%	-7.70%	54.90%
Earnings Yield	-27.99%	-25.15%	-8.15%	-12.12%	-1.83%	-
FCF Yield	3.35%	3.01%	-5.97%	-19.85%	-	-